← All industries · Healthcare
Industry

Health Care Services

Every analyzed stock in Health Care Services — 19 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
ALPS
Alps Group Inc
Valuation N/A
Healthcare
Price$0.33
Model IV—
P/IV—
Limited data — see page
ATPC
Agape ATP Corp
Deeply undervalued
Healthcare Risk 33 · Moderate
Price$2.49
Model IV$5.00
P/IV0.98
Discount 50% Return to IV: +100.6%
Market implies -22.1%/yr vs model +10.6% · below model
DCGO
DocGo Inc.
Deeply undervalued
Healthcare Risk 28 · Moderate
Price$0.65
Model IV$1.03
P/IV0.54
Discount 36% Return to IV: +57.5%
Market implies -7.0%/yr vs model +3.2% · below model
EUDA
EUDA Health Holdings Ltd
Deeply overvalued
Healthcare Risk 55 · Elevated
Price$14.17
Model IV$9.57
P/IV1.89
Premium +48% Return to IV: -32.5%
Market implies -7.6%/yr vs model +10.6% · below model
EUDAW
EUDA Health Holdings Ltd
Valuation N/A
Healthcare Risk 51 · Elevated
Price$0.03
Model IV—
P/IV—
Limited data — see page
INNV
InnovAge Holding Corp.
Deeply overvalued
Healthcare Risk 60 · High
Price$10.43
Model IV$2.09
P/IV3.63
Premium +398% Return to IV: -79.9%
Market implies +28.3%/yr vs model +8.3% · above model
LFST
LifeStance Health Group, Inc.
Deeply overvalued
Healthcare Risk 61 · High
Price$12.22
Model IV$3.24
P/IV2.38
Premium +277% Return to IV: -73.5%
Market implies +31.6%/yr vs model +17.6% · above model
NIVFW
NewGenIvf Group Ltd
Deeply undervalued
Healthcare Risk 44 · Elevated
Price$0.02
Model IV$31.21
P/IV0.00
Discount 100% Return to IV: +178,242.9%
Market implies -50.0%/yr vs model +11.7% · below model
OMDA
Omada Health, Inc.
Deeply undervalued
Healthcare Risk 28 · Moderate
Price$24.37
Model IV$54.67
P/IV0.33
Discount 55% Return to IV: +124.4%
Market implies -14.6%/yr vs model +45.6% · below model
PIII
P3 Health Partners Inc.
Valuation N/A
Healthcare Risk 40 · Elevated
Price$10.96
Model IV—
P/IV—
Market implies -50.0%/yr vs model +26.0% · below model
PIIIW
P3 Health Partners Inc.
Valuation N/A
Healthcare Risk 31 · Moderate
Price$0.01
Model IV—
P/IV—
Limited data — see page
PNTG
Pennant Group, Inc.
Overvalued
Healthcare Risk 46 · Elevated
Price$39.32
Model IV$30.38
P/IV1.13
Premium +29% Return to IV: -22.7%
Market implies +15.9%/yr vs model +17.8% · in line
PRVA
Privia Health Group, Inc.
Overvalued
Healthcare Risk 56 · Elevated
Price$21.54
Model IV$17.71
P/IV1.21
Premium +22% Return to IV: -17.8%
Market implies +16.5%/yr vs model +18.2% · in line
SRTA
Strata Critical Medical, Inc.
Valuation N/A
Healthcare Risk 31 · Moderate
Price$6.03
Model IV—
P/IV—
Market implies +10.4%/yr vs model +40.6% · below model
TALK
Talkspace, Inc.
Fairly valued
Healthcare Risk 42 · Elevated
Price$5.24
Model IV$4.75
P/IV1.09
Premium +10% Return to IV: -9.3%
Market implies -4.2%/yr vs model +19.1% · below model
TALKW
Talkspace, Inc.
Deeply undervalued
Healthcare Risk 31 · Moderate
Price$0.00
Model IV$0.26
P/IV0.01
Discount 100% Return to IV: +129,900.0%
Market implies -50.0%/yr vs model +15.0% · below model
USPH
U S PHYSICAL THERAPY INC /NV
Fairly valued
Healthcare Risk 36 · Moderate
Price$78.48
Model IV$81.30
P/IV0.79
Discount 3% Return to IV: +3.6%
Market implies +7.6%/yr vs model +11.5% · below model
VSEE
VSEE HEALTH, INC.
Valuation N/A
Healthcare Risk 36 · Moderate
Price$0.03
Model IV—
P/IV—
Market implies -50.0%/yr vs model +15.0% · below model
WGS
GeneDx Holdings Corp.
Deeply overvalued
Healthcare Risk 55 · Elevated
Price$78.08
Model IV$28.45
P/IV1.83
Premium +174% Return to IV: -63.6%
Market implies +14.2%/yr vs model +19.1% · below model